Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 82% ± 16% | |
GABAergic neuron | 10 studies | 59% ± 27% | |
oligodendrocyte precursor cell | 9 studies | 45% ± 12% | |
endothelial cell | 7 studies | 49% ± 21% | |
macrophage | 7 studies | 33% ± 7% | |
microglial cell | 7 studies | 30% ± 19% | |
type I pneumocyte | 7 studies | 65% ± 26% | |
oligodendrocyte | 7 studies | 28% ± 20% | |
interneuron | 6 studies | 58% ± 22% | |
naive B cell | 6 studies | 18% ± 2% | |
B cell | 6 studies | 33% ± 9% | |
neuron | 5 studies | 49% ± 17% | |
Mueller cell | 4 studies | 58% ± 20% | |
OFF-bipolar cell | 4 studies | 47% ± 30% | |
amacrine cell | 4 studies | 37% ± 7% | |
retina horizontal cell | 4 studies | 40% ± 13% | |
retinal ganglion cell | 4 studies | 46% ± 19% | |
astrocyte | 4 studies | 39% ± 26% | |
GABAergic interneuron | 3 studies | 73% ± 12% | |
epithelial cell | 3 studies | 36% ± 13% | |
retinal bipolar neuron | 3 studies | 33% ± 24% | |
GABAergic amacrine cell | 3 studies | 57% ± 12% | |
ON-bipolar cell | 3 studies | 40% ± 19% | |
glycinergic amacrine cell | 3 studies | 24% ± 4% | |
club cell | 3 studies | 24% ± 1% | |
type II pneumocyte | 3 studies | 29% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 351.38 | 650 / 653 | 74% | 4.91 | 450 / 605 |
brain | 84% | 240.19 | 2216 / 2642 | 62% | 3.45 | 436 / 705 |
lung | 98% | 186.15 | 569 / 578 | 29% | 1.46 | 338 / 1155 |
adrenal gland | 89% | 79.38 | 230 / 258 | 19% | 0.99 | 44 / 230 |
spleen | 99% | 88.68 | 239 / 241 | 0% | 0 | 0 / 0 |
kidney | 38% | 17.82 | 34 / 89 | 3% | 0.08 | 26 / 901 |
intestine | 33% | 24.29 | 320 / 966 | 2% | 0.06 | 8 / 527 |
bladder | 29% | 18.14 | 6 / 21 | 5% | 0.24 | 23 / 504 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.45 | 8 / 29 |
uterus | 10% | 9.79 | 17 / 170 | 10% | 0.36 | 45 / 459 |
ovary | 8% | 3.86 | 14 / 180 | 5% | 0.14 | 21 / 430 |
skin | 0% | 0.05 | 2 / 1809 | 8% | 0.24 | 40 / 472 |
pancreas | 0% | 0 | 0 / 328 | 8% | 0.20 | 15 / 178 |
peripheral blood | 7% | 3.08 | 66 / 929 | 0% | 0 | 0 / 0 |
muscle | 7% | 2.90 | 56 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.12 | 5 / 80 |
stomach | 3% | 2.13 | 11 / 359 | 2% | 0.05 | 7 / 286 |
prostate | 2% | 0.60 | 4 / 245 | 1% | 0.01 | 3 / 502 |
esophagus | 2% | 0.93 | 24 / 1445 | 1% | 0.01 | 1 / 183 |
breast | 0% | 0 | 0 / 459 | 2% | 0.05 | 24 / 1118 |
adipose | 2% | 0.68 | 19 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.04 | 6 / 406 |
blood vessel | 1% | 0.60 | 16 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.11 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006397 | Biological process | mRNA processing |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008143 | Molecular function | poly(A) binding |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0008266 | Molecular function | poly(U) RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | KHDRBS2 |
Protein name | Alternative protein KHDRBS2 KH domain-containing, RNA-binding, signal transduction-associated protein 2 KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (hSLM-1) |
Synonyms | SLM1 |
Description | FUNCTION: RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds both poly(A) and poly(U) homopolymers. Phosphorylation by PTK6 inhibits its RNA-binding ability (By similarity). Induces an increased concentration-dependent incorporation of exon in CD44 pre-mRNA by direct binding to purine-rich exonic enhancer. Can regulate alternative splicing of NRXN1 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. Regulates cell-type specific alternative splicing of NRXN1 at AS4 and acts synergystically with SAM68 in exon skipping. In contrast acts antagonistically with SAM68 in NRXN3 exon skipping at AS4. Its phosphorylation by FYN inhibits its ability to regulate splice site selection. May function as an adapter protein for Src kinases during mitosis. . |
Accessions | ENST00000281156.5 A0A6Q8PGH5 L8ECN3 Q5VWX1 ENST00000675091.1 |